[Impregnated polyester prostheses: a theoretical advantage]. 1996

J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
Service de Chirurgie Vasculaire, Hôpital Henri Mondor, Créteil.

Leak-proof polyester grafts impregnated with collagen, gelatine or albumin are routinely used in vascular surgery. Theoretically, there are several advantages: no need for pre-coagulation, reduced operation time and graft manipulation, less blood loss during the operative period, better healing with a potentially greater resistance to infection. We analyzed all the publications in scientific journals to verify whether these theoretical advantages are validated by clinical trials. There have been 12 non-comparative series reporting favourable results but the lack of control groups makes it difficult to draw conclusions. Five comparative series with random assignment of patients have been reported. None of these series showed a substantial benefit from impregnation. Thus the use of an impregnated polyester graft would not appear to be justified for routine standard aorto-iliac surgery. Conversely, although no evidence has been provided by a comparative study, the major risk of haemorrhage in procedures such as extra-corporal circulation, the thoracic or abdominal aorta and in patients with a coagulation disorder, impregnated graft probably constitute an important progress.

UI MeSH Term Description Entries
D011091 Polyesters Polymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours. Polyester
D011474 Prosthesis Design The plan and delineation of prostheses in general or a specific prosthesis. Design, Prosthesis,Designs, Prosthesis,Prosthesis Designs
D001807 Blood Vessel Prosthesis Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels. Vascular Prosthesis,Blood Vessel Prostheses,Tissue-Engineered Vascular Graft,Graft, Tissue-Engineered Vascular,Grafts, Tissue-Engineered Vascular,Prostheses, Blood Vessel,Prostheses, Vascular,Prosthesis, Blood Vessel,Prosthesis, Vascular,Tissue Engineered Vascular Graft,Tissue-Engineered Vascular Grafts,Vascular Graft, Tissue-Engineered,Vascular Grafts, Tissue-Engineered,Vascular Prostheses,Vessel Prostheses, Blood,Vessel Prosthesis, Blood
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005780 Gelatin A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories. Gelafusal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000418 Albumins Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating. Albumin
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
September 1999, Annals of vascular surgery,
J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
January 1996, ASAIO journal (American Society for Artificial Internal Organs : 1992),
J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
January 1999, ASAIO journal (American Society for Artificial Internal Organs : 1992),
J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
January 1989, Biomaterials,
J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
January 1980, Polimery w medycynie,
J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
May 1987, Biomaterials,
J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
January 1983, Aktuelle Probleme in Chirurgie und Orthopadie,
J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
January 2002, Journal of biomaterials science. Polymer edition,
J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
May 2001, Journal of vascular surgery,
J P Becquemin, and A Cavillon, and P Desgranges, and E Allaire, and D Melliere
January 1983, Medical progress through technology,
Copied contents to your clipboard!